Cargando…

No Evaluation of Serum P53 Levels in Iraqi Female Breast Cancer Patients

Breast cancer is the most common cancer diagnosed and the second leading cause of cancer death among Iraqi women. The population was exposed to high levels of depleted uranium following the first and second Gulf Wars and this might be a risk factor. Protein 53 (p53) or Tumor protein 53 (Tp53) was or...

Descripción completa

Detalles Bibliográficos
Autores principales: Jabir, Ferdous A, Hoidy, Wisam H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720665/
https://www.ncbi.nlm.nih.gov/pubmed/28952299
http://dx.doi.org/10.22034/APJCP.2017.18.9.2551
_version_ 1783284698153222144
author Jabir, Ferdous A
Hoidy, Wisam H
author_facet Jabir, Ferdous A
Hoidy, Wisam H
author_sort Jabir, Ferdous A
collection PubMed
description Breast cancer is the most common cancer diagnosed and the second leading cause of cancer death among Iraqi women. The population was exposed to high levels of depleted uranium following the first and second Gulf Wars and this might be a risk factor. Protein 53 (p53) or Tumor protein 53 (Tp53) was originally defined as an oncogenic protein. The aim of the study was to evaluate P-53 serum concentrations in fifty Iraqi female breast cancer patients and twenty five healthy volunteers using the ELISA technique. All these patients attended the Teaching Hospital of AL Diwaniyah during the period between June 2016 to March 2017. The mean values for TP53 concentration in patients with breast cancer and apparently healthy groups were 47+33.5 U/ml and 27. 8+12.7 U/ml, respectively. The results showed no significantly difference, in contrast to most studies conducted elsewhere in the world.
format Online
Article
Text
id pubmed-5720665
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-57206652018-01-04 No Evaluation of Serum P53 Levels in Iraqi Female Breast Cancer Patients Jabir, Ferdous A Hoidy, Wisam H Asian Pac J Cancer Prev Research Article Breast cancer is the most common cancer diagnosed and the second leading cause of cancer death among Iraqi women. The population was exposed to high levels of depleted uranium following the first and second Gulf Wars and this might be a risk factor. Protein 53 (p53) or Tumor protein 53 (Tp53) was originally defined as an oncogenic protein. The aim of the study was to evaluate P-53 serum concentrations in fifty Iraqi female breast cancer patients and twenty five healthy volunteers using the ELISA technique. All these patients attended the Teaching Hospital of AL Diwaniyah during the period between June 2016 to March 2017. The mean values for TP53 concentration in patients with breast cancer and apparently healthy groups were 47+33.5 U/ml and 27. 8+12.7 U/ml, respectively. The results showed no significantly difference, in contrast to most studies conducted elsewhere in the world. West Asia Organization for Cancer Prevention 2017 /pmc/articles/PMC5720665/ /pubmed/28952299 http://dx.doi.org/10.22034/APJCP.2017.18.9.2551 Text en Copyright: © Asian Pacific Journal of Cancer Prevention http://creativecommons.org/licenses/BY-SA/4.0 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
spellingShingle Research Article
Jabir, Ferdous A
Hoidy, Wisam H
No Evaluation of Serum P53 Levels in Iraqi Female Breast Cancer Patients
title No Evaluation of Serum P53 Levels in Iraqi Female Breast Cancer Patients
title_full No Evaluation of Serum P53 Levels in Iraqi Female Breast Cancer Patients
title_fullStr No Evaluation of Serum P53 Levels in Iraqi Female Breast Cancer Patients
title_full_unstemmed No Evaluation of Serum P53 Levels in Iraqi Female Breast Cancer Patients
title_short No Evaluation of Serum P53 Levels in Iraqi Female Breast Cancer Patients
title_sort no evaluation of serum p53 levels in iraqi female breast cancer patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720665/
https://www.ncbi.nlm.nih.gov/pubmed/28952299
http://dx.doi.org/10.22034/APJCP.2017.18.9.2551
work_keys_str_mv AT jabirferdousa noevaluationofserump53levelsiniraqifemalebreastcancerpatients
AT hoidywisamh noevaluationofserump53levelsiniraqifemalebreastcancerpatients